Confirmatory Trials for Drugs Granted Conditional Approval by the Chinese National Medical Products Administration
This cross-sectional study analyzes differences in pivotal and confirmatory trial characteristics for drugs granted conditional approval in China.
Authors
- Caijun Yang (ORCID: https://orcid.org/0000-0001-5127-7075)
- Yu Fang
- Shuchen Hu (ORCID: https://orcid.org/0000-0001-7146-6463)
- Xingyu Liu (ORCID: https://orcid.org/0009-0007-5748-3938)
- Yun Tian (ORCID: https://orcid.org/0000-0001-9300-1827)
- Xiaoyong Liu (ORCID: https://orcid.org/0009-0007-1438-805X)
- Jinwei Zhang (ORCID: https://orcid.org/0000-0002-5772-5374)
Institutions
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.4601
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China